Tang Capital Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Tang Capital Management’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,150,000	Closed	-$6.72M	–	124
2022 Q4	$6.72M	Buy	1,150,000 +146,983	+15%	+$773K	0.98%	29
2022 Q3	$6.72M	Buy	+1,003,017	New	+$6.08M	0.82%	39

Tang Capital Management's CNCE Position: Q1 2023 in Review

Tang Capital Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 1,150,000 shares — an estimated $6.72M sold.

Tang Capital Management first reported a position in CNCE in Q3 2022 and held it in 2 quarters. The position peaked at $6.72M in Q3 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.

Tang Capital Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Tang Capital Management sold 1,150,000 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $6.72M.
Tang Capital Management first reported a position in Concert Pharmaceuticals, Inc. in Q3 2022 and held it in 2 quarters.
Tang Capital Management's Concert Pharmaceuticals, Inc. position peaked at $6.72M in Q3 2022.
0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.

Based on Tang Capital Management's 13F filing for Q1 2023, filed 15 May 2023.